Xylem Inc. (NYSE:XYL) Shares Sold by Captrust Financial Advisors

Captrust Financial Advisors cut its stake in Xylem Inc. (NYSE:XYL) by 4.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 39,118 shares of the industrial products company’s stock after selling 1,753 shares during the period. Captrust Financial Advisors’ holdings in Xylem were worth $5,282,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of XYL. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Xylem by 1.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock worth $465,760,000 after acquiring an additional 32,645 shares during the last quarter. Swedbank AB grew its holdings in shares of Xylem by 22.8% during the 3rd quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock worth $403,953,000 after purchasing an additional 554,609 shares during the period. Mirova US LLC increased its position in Xylem by 2.0% during the 2nd quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company’s stock worth $254,526,000 after purchasing an additional 36,013 shares in the last quarter. Impax Asset Management Group plc raised its holdings in Xylem by 1.0% in the third quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock valued at $226,555,000 after buying an additional 15,825 shares during the period. Finally, DekaBank Deutsche Girozentrale lifted its position in Xylem by 2.2% during the second quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company’s stock valued at $227,364,000 after buying an additional 36,601 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Stock Performance

Shares of NYSE XYL opened at $127.68 on Wednesday. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. The firm’s 50-day moving average price is $129.22 and its two-hundred day moving average price is $133.54. Xylem Inc. has a 52-week low of $104.95 and a 52-week high of $146.08. The stock has a market capitalization of $31.02 billion, a P/E ratio of 37.33, a P/E/G ratio of 2.34 and a beta of 1.05.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.11. The business had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The business’s revenue was up .2% on a year-over-year basis. During the same quarter last year, the business posted $0.99 EPS. As a group, sell-side analysts forecast that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, November 26th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.13%. Xylem’s dividend payout ratio (DPR) is presently 42.11%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. TD Cowen dropped their price objective on shares of Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research report on Wednesday, November 6th. UBS Group assumed coverage on Xylem in a report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price target for the company. Royal Bank of Canada reduced their price objective on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Finally, Robert W. Baird lowered their target price on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and an average target price of $149.64.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.